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WHAT THIS PAPER ADDS
 This study presents data from a contemporary series of patients undergoing EVAR and demonstrates that changing to operator-
controlled imaging is a useful and achievable method of improving safety and efﬁciency during EVAR.a r t i c l e i n f o
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Introduction: Adoption of endovascular aneurysm repair (EVAR) has led to signiﬁcant reductions in the
short-term morbidity and mortality associated with abdominal aortic aneurysm (AAA) repair. However,
EVAR may expose both patient and interventionalist to potentially harmful levels of radiation, particu-
larly as more complex procedures are undertaken. The aim of this study was to assess whether changing
from radiographer-controlled imaging to a system of operator-controlled imaging (OCI) would inﬂuence
radiation exposure, screening time or contrast dose during EVAR.
Method: Retrospective analysis identiﬁed patients that had undergone elective EVAR for infra-renal AAA
before or after the change to operator-controlled imaging. Data were collected for radiation dose
(measured as dose area product; DAP), screening time, total delivered contrast volume and operative
duration. Data were also collected for maximum aneurysm diameter, patient age, gender and body mass
index.
Results: 122 patients underwent EVAR for infra-renal AAA at a single centre between January 2011 and
December 2011. 57 of these were prior to installation of OCI and 65 after installation. Median DAP was
signiﬁcantly lower after installation of OCI (4.9 mGy m2; range 1.25e13.3) than it had been before
installation (6.9 mGy m2; range 1.91e95.0) (p ¼ 0.005). Median screening times before and after
installation of OCI were 20.0 min and 16.2 min respectively (p ¼ 0.027) and median contrast volumes
before and after the change to OCI were 100 ml and 90 ml respectively (p ¼ 0.21).
Conclusion: Introduction of operator-controlled imaging can signiﬁcantly reduce radiation exposure
during EVAR, with particular reduction in the number of ‘higher-dose’ cases.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Over the past two decades, endovascular repair (EVAR) has
become widely accepted as a safe and effective alternative to open
repair (OR) for the treatment of abdominal aortic aneurysms (AAA).
Whilst this technique has brought with it signiﬁcant reductions in
short-term morbidity and mortality, it has also led to concerns
about the degree to which both patient and interventionalist (i.e.fax: þ44 (0) 2087253495.
.
ciety for Vascular Surgery. Publishesurgeon or interventional radiologist) are exposed to radiation
during treatment and follow-up. Efforts to reduce the postoperative
radiation burden have seen a progressive shift towards duplex
ultrasound for graft surveillance rather than repeated computed
tomography (CT).1 As a result, concerns about the amount of radi-
ation delivered to patients are increasingly focused on intra-
operative exposure. This is particularly relevant as operators
become more skilled and are undertaking increasingly complex
procedures that necessitate prolonged ﬂuoroscopic imaging.
The potential signiﬁcance of radiation exposure is well recog-
nized in other radiographic procedures2 and effects can be classi-
ﬁed as either deterministic (causing direct tissue damage) ord by Elsevier Ltd. All rights reserved.
Table 1
Patient characteristics.
Before installation
of OCI (SD) n ¼ 57
After installation
of OCI (SD) n ¼ 65
pb
Mean age (yrs) 76.1 (7.5) 76.6 (8.3) 0.73
Gender (n ¼ male/n
¼ female)
49/8 57/8 0.79c
Mean Body Mass Indexa 26.5 (3.8) 27.4 (4.7) 0.29
Mean maximum
aneurysm
diameter (mm)
62 (9.1) 63 (10.2) 0.52
a n ¼ 48(before)/45(after).
b Student’s t-test.
c p-value based on Fisher’s exact test.
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gested that radiation exposure may reach a level that is theoreti-
cally sufﬁcient to cause deterministic effects in up to 30% of EVAR
cases.3,4 However, whilst deterministic effects have often been re-
ported during coronary angiography,5 reports of direct radiation
damage during EVAR are scarce.6,7 This may be due to a paucity of
radiation data relating to EVAR, the result of the frequent change in
focal point during this procedure, or more likely, the non-reporting
of patient radiation injuries.
While a number of authors have assessed the level of radiation
exposure during EVAR,3,8,9 few have explicitly examined ways in
which this exposure might be reduced. This study used a planned
change in theatre conﬁguration to assess whether changing to
a system of operator-controlled imaging (OCI) would inﬂuence
radiation exposure, operative duration, screening time, or contrast
dose during EVAR.
Methods
Datawere collected retrospectively for consecutive patients that
underwent elective EVAR for infra-renal AAA at a single centre
between January 2011 and December 2011. This time period was
chosen to provide data from patients both before and after
conversion to OCI, which occurred on 29th June 2011. Patients who
underwent more complex forms of endografting, such as thoracic,
fenestrated, or iliac-branch grafts were excluded, as were patients
who underwent insertion of aortouniiliac endografts (AUI), in order
tominimizemorphological heterogeneity. Patients who underwent
EVAR solely for the treatment of iliac artery aneurysm were also
excluded, whilst those with both AAA and iliac aneurysm were
included, since variations in iliac size are common and were not
considered likely to signiﬁcantly confound the data.
The variables of primary interest were: Intraoperative radiation
dose expressed as dose area product (DAP in mGy m2); delivered
contrast medium volume (ml); overall screening time and opera-
tive duration. Data were also collected for the individual operators,
maximum aneurysm diameter and patient age, gender and body
mass index (BMI). All data were gathered from theatre logbooks,
Picture Archiving and Communication System (PACS), patient case-
notes and Electronic Patient Records (EPR).
All procedures were performed in a single operating theatre by
a consultant vascular interventionalist experienced in EVAR or
a ﬁnal-year trainee under consultant supervision. Prior to June 29th
2011, procedural imagingwas performed using an OEC 9800Mobile
C-arm (GE Medical Systems, Utah, USA), with a standard, static,
radiolucent theatre table. For procedures after 29th June 2011,
imaging was carried out using an OEC 9900 MD Elite (Vascular)
Mobile C-arm (GEMedical Systems, Utah, USA), with a Stille ImagiQ
cardiovascular table (Stille-Sonesta Inc., Texas, USA) and multiple
video output screens on a NuBoom articulating support (GE
Medical Systems, Utah, USA). The new imaging system is operated
via a sterile, tableside control panel that gives the interventionalist
precise, fully motorized control of the C-arm, patient position and
imaging mode. Though image acquisition is the same resolution on
old and new systems, high deﬁnition video output screens also
offer improved anatomical visualization.
Low-dose ﬂuoroscopy and high-dose ‘digital acquisition’ were
performed using pulse-beam ﬂuoroscopy at 12 frames per second.
The method of delivering contrast media was unchanged
throughout the study period and was via a Medrad Mark V Plus
angiographic injector (Medrad UK Ltd., Ely, UK).
DAP was recorded by transmission ionization chambers integral
to both old and new C-arms. These were calibrated according to
manufacturers instructions. Screening time was also recorded
automatically by the software in both old and new C-arms. Thetime recorded was a combined total for low-dose ﬂuoroscopy and
high-dose digital-acquisition. Contrast medium volume was docu-
mented as the total volume delivered throughout the procedure.
All patients underwent preoperative CT-scanning to assess
aneurysm morphology and cases were planned using 3mensio
Vascular software (3mensio Medical Imaging BV, Bilthoven,
Netherlands). Other than the change to OCI, there was no change in
operative protocol during the study period, nor any additional
training with regard to radiation safety (that might have inﬂuenced
the dose delivered by the operator).Results
122 patients underwent elective EVAR for infra-renal AAA
between 4th January 2011 and 17th December 2011. Of these, 57
patients had their intervention prior to installation of OCI and 65
patients underwent EVAR after installation of OCI. Mean values for
age, BMI, and maximum aneurysm diameter were not signiﬁcantly
different before and after the change in theatre conﬁguration. The
male/female ratio was also unchanged (Table 1).
Median DAP values before and after change in theatre conﬁgu-
ration were 6.9 mGy m2 and 4.9 mGy m2 respectively, representing
a 29% reduction in median emitted radiation dose (p ¼ 0.005).
Notably, the range of values was far greater prior to the introduc-
tion of OCI, with DAP values exceeding 23.5 mGy cm2 in 9 of 57
cases. After introduction of the new system, the highest recorded
DAP was 13.3 mGy m2 (Table 2).
Median total screening time was also signiﬁcantly lower after
installation of OCI (16.2 min) than before installation (20.0 min)
(p ¼ 0.027), though there was no signiﬁcant correlation between
total screening time and DAP (r¼ 0.13). Operative durationwas also
reduced following the change to OCI (130 min before; 120 min
after), as was contrast dose (100 ml before; 90 ml after), but both of
these were non-signiﬁcant (p ¼ 0.28 and p ¼ 0.21 respectively)
(Table 2).
Consultant interventionalists performed the majority of cases
both before (65%) and after (62%) installation of OCI.
Zenith endografts (Cook Medical Inc., Bloomington, USA) were
the most frequently used device both before (n ¼ 40) and after
(n ¼ 49) the change to OCI. All remaining cases were performed
using Endurant devices (Medtronic, Minneapolis, USA).Discussion
Exposure to radiation is an undesirable yet inevitable conse-
quence of all ﬂuoroscopic procedures, particularly those that
involve complex endovascular intervention. Although other
authors have attempted to quantify the level of radiation exposure
during EVAR3,8,9 little work has been done to assess whether more
Table 2
Median values before and after change to OCI.
Median value
before OCI (range)
Median value
with OCI (range)
p valueb
Dose area product
(mGy m2)
6.9 (1.91e95.0) 4.9 (1.25e13.3) 0.005
Screening time (min) 20.0 (4.8e49.3) 16.2 (3.1e51.1) 0.027
Contrast dose (ml)a 100 (60e300) 90 (50e180) 0.21
Operative duration (min) 130 (65e240) 120 (60e205) 0.44
a n ¼ 45(before)/51(after).
b Mann-Whitney U test.
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could reduce radiation exposure for both patient and surgeon.
Radiation levels recorded during this study were in keeping
with those reported elsewhere, with median DAP values after
installation of OCI being comparable to the optimum series in the
literature.8,10,11 Whilst DAP does not provide a direct measure of
absolute radiation dose received by the patient or interventionalist,
it has been shown to have a strong correlation with peak skin dose
(PSD) during EVAR (r2 ¼ 0.923).10,11 PSD is a direct measurement of
radiation dose derived from radiochromic ﬁlms placed beneath the
patient throughout the procedure. This strong correlation therefore
supports the use of DAP as a surrogate measure of received radia-
tion dose. Furthermore, whilst entrance skin dose (ESD) or effective
dose (ED) are often reported for angiographic procedures, both of
these alternative measures are dependent upon the position of the
X-ray tube relative to the patient. Since this relative position varies
so signiﬁcantly during EVAR, DAP was considered to be the most
useful surrogate of radiation exposure in this setting.
What is most notable from our results is that the change to OCI
not only reduced median DAP, but also dramatically reduced the
range of DAP values observed (Fig. 1). Prior to introduction of OCI,
the range of DAP values was 1.9e95.0 mGy m2 (with only a single
DAP value over 78.3 mGy m2), which is broadly similar to ﬁgures
presented by Kuhelj et al. and Weerakoddy et al., who observed
ranges of 3.5e70 mGy2 m2 and 9e66 mGy m2 respectively.3,7 After
installation of OCI, however, the maximum recorded DAP during 65
consecutive cases was only 13.3 mGy m2, which is lower than the
maximum recorded DAP in any series of bifurcated endografts
published to date.8,10,12
Scrutiny of the nine cases inwhich DAP exceeded 20mGym2 (all
prior to OCI) did not reveal any clear intraoperative difﬁculty, nor
any signiﬁcant differences in BMI, gender, maximum aneurysm
diameter or type of endograft compared to patients who received
lower radiation doses. The mean age of these higher-dose patients
was greater than in the low-dose group (80.1 yrs versus 76.6 yrs),
but this alone does not explain the dose differences. OperatorFigure 1. Radiation exposure in cases before/after change to OCI.inexperience was also excluded as a sole cause of higher radiation
exposure, since six of the nine higher-dose cases were performed
by consultant interventionalists (which is in keeping with the total
proportion of cases performed by consultants). Furthermore, the
same group of interventionalists performed the majority of
procedures both before and after the change to OCI, conﬁrming that
reduced DAP values were not simply the result of change in
operator.
This reduction in maximum delivered dose is particularly rele-
vant in attempts to reduce the impact of radiation on patients.
Whilst mean/median DAP values give a useful guide to likely
cumulative exposure for the interventionalist, it is the cases at the
upper end of the dose range that are most likely to result in
deterministic effects for the patient. Since a signiﬁcant proportion
of patients undergoing EVAR may exceed the theoretical threshold
for deterministic tissue damage,3 every effort must be made to
reduce the number of these ‘high-dose’ cases.
In contrast to other authors,13e15 our results showed no corre-
lation between DAP and overall screening time (i.e. low-dose
ﬂuoroscopy and high-dose digital acquisition combined) or BMI.
Nor was there any correlation between DAP and the volume of
contrast used. Whilst median DAP was reduced by nearly 30%
following introduction of OCI, there was only a 19% fall in overall
screening time (p ¼ 0.027) and a 10% reduction in contrast dose
(p ¼ 0.28). This suggests that there was a reduction in the number
or duration of high-dose digital acquisition ‘runs’ after introduction
of OCI, since this would signiﬁcantly reduce DAP whilst having
relatively little effect on overall screening time. This may be
because OCI provides improved anatomical clarity by allowing the
operator to position the patient more accurately before performing
high-dose ‘runs’, thereby limiting the number/length of runs
necessary to assess graft position during deployment. Prospective
data collection would be necessary to conﬁrm these assertions
since this was a retrospective study and number and length of runs
were not routinely recorded.
Although high-dose cases may be responsible for possible
deterministic effects, the risk of stochastic effectse and the need to
reduce routine radiation exposuree should not be underestimated.
It has been suggested that the lifetime fatal-cancer risk may be
greater than 1% for patients undergoing EVAR,16 and whilst some
patients may be very elderly and not live long enough for stochastic
effects to manifest (typically 10e20 yrs),17,18 the introduction of
AAA screening programmes has meant that increasing numbers of
patients are being treated at 65e70 yrs of age. In addition, thoracic
endografts are now being used with increasing frequency to treat
young trauma patients who will require life-long surveillance. The
risk of stochastic effects must therefore be minimized whenever
possible.
The low DAP values and reduced screening times achieved in
this study demonstrate that interventionalists working in adapted
operating theatres can enhance the safety and efﬁciency of EVAR by
changing to OCI. This technique not only reduces radiation expo-
sure to both patient and interventionalist, but also implies that
fewer staff are required to perform the procedure e a factor
particularly beneﬁcial in the emergency setting when availability of
staff is often low. Although these results were achieved with
a mobile C-arm, it is likely that future progression to full-hybrid
theatres with ﬁxed, high-quality imaging under operator control
may offer further improvements in performance.
With increasing evidence that EVAR can be performed with
consistently low radiation doses, it may also be feasible to establish
clearer guidelines for acceptable exposure during this procedure
and ensure that it is ‘as low as reasonably practicable’ (ALARP).19
Though there will always be a balance between image quality
and radiation dose, greater awareness of the issues would allow
G. Peach et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 395e398398interventionalists to monitor radiation levels just as they monitor
other operative outcomes and ensure high doses are not being
delivered unnecessarily.
Conclusion
Operator-controlled imaging allows surgeons and interven-
tional radiologists to perform EVAR with greater independence
while signiﬁcantly reducing the delivered radiation dose. Further
data are necessary to verify whether changing to OCI is sufﬁcient to
completely eliminate ‘high-dose’ cases during infra-renal EVAR and
clarify whether similar improvements can be achieved in the
treatment of more complex aneurysms.
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